Executive Dumps Over 14,000 Shares of Biotech Stock, Valued at $2.3 Million
· finance.yahoo.com
Ian Clark exercised stock options at $50.57 and immediately liquidated the position as the precision oncology company trades near $160 per share.
Guardant Health serves oncologists, hospitals, and cancer centers globally, with primary customers including healthcare providers treating patients with advance...